Effects of Renal Failure and Dialysis on Cefazolin Pharmacokinetics
Serum and urinary levels of cefazolin were determined after a 500-mg parenteral dose in eight azotemic volunteers. The mean peak serum concentration was 1.5 to 5 times the levels obtained in nonazotemic patients. The serum half-life of cefazolin was increased significantly. In patients on dialysis,...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
1975
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC429262/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1164008/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.8.1.63 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|